Table 4.
Multivariate analysis of patients’ 5-year overall survival
| Variable | P-value | Relative risk (95 % CI) |
|---|---|---|
| Sex (male/female) | 0.193 | 1.944 (0.737–6.710) |
| Lymphatic invasion (ly1–3/ly0) | 0.222 | 1.628 (0.756–3.925) |
| Tumor depth (pT3–4/pT1–2) | 0.26 | 1.911 (0.644–7.047) |
| Lymph node metastasis (pN1/pN0) | 0.025a | 3.852 (1.169–16.335) |
| Pathological stage (pStage III–IV/I–II) | 0.814 | 0.856 (0.215–2.898) |
| c-Met expression (high/low) | 0.033a | 2.237 (1.066–5.190) |
| HGF expression (high/low) | 0.821 | 1.075 (0.572–2.012) |
CI confidence interval, HGF hepatocyte growth factor
aindicates statistical significance